Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / BIOTECH ETF
-
Number of holders
-
75
-
Total 13F shares, excl. options
-
799,399
-
Shares change
-
+745,506
-
Total reported value, excl. options
-
$82,328,378
-
Value change
-
+$76,813,156
-
Put/Call ratio
-
45.4%
-
Number of buys
-
68
-
Number of sells
-
-2
-
Price
-
$102.34
Significant Holders of VANECK ETF TRUST - BIOTECH ETF (BBH) as of Q2 2016
79 filings reported holding BBH - VANECK ETF TRUST - BIOTECH ETF as of Q2 2016.
VANECK ETF TRUST - BIOTECH ETF (BBH) has 75 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 799,399 shares
.
Largest 10 shareholders include GOLDMAN SACHS GROUP INC (101,814 shares), UBS Group AG (81,663 shares), MORGAN STANLEY (69,807 shares), MURPHY CAPITAL MANAGEMENT INC (44,572 shares), ROYAL BANK OF CANADA (41,163 shares), BANQUE PICTET & CIE SA (35,500 shares), Virtu Financial LLC (32,958 shares), Strategic Financial Services, Inc, (27,062 shares), LPL Financial LLC (24,738 shares), and Timber Hill LLC (23,396 shares).
This table shows the top 75 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.